Wave Life Sciences Ltd. (WVE)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:662
% of all portfolios:0.009%
History Portfolio Manager Activity Share change % change to portfolio
Q2  2024
Lee Ainslie - Maverick Capital Reduce 0.24% 18,718 0.00
Q1  2024
Lee Ainslie - Maverick Capital Reduce 8.99% 759,725 0.09
Q4  2023
Lee Ainslie - Maverick Capital Add 28.11% 1,853,485 0.19
Q3  2023
Lee Ainslie - Maverick Capital Reduce 0.04% 2,459 0.00
Q1  2023
Lee Ainslie - Maverick Capital Reduce 7.06% 500,886 0.06
Q4  2022
Lee Ainslie - Maverick Capital Reduce 9.07% 707,555 0.12
Q2  2022
Lee Ainslie - Maverick Capital Add 39.54% 2,211,830 0.18
Q4  2021
Lee Ainslie - Maverick Capital Add 75.16% 2,400,000 0.09
Q3  2021
Lee Ainslie - Maverick Capital Add 3.41% 105,258 0.01
Q2  2021
Lee Ainslie - Maverick Capital Add 0.16% 4,930 0.00
Q1  2021
Lee Ainslie - Maverick Capital Buy 3,083,201 0.16
Q1  2020
Meridian Contrarian Fund Sell 100.00% 160,000 0.23
Q4  2019
Meridian Contrarian Fund Reduce 24.53% 52,000 0.07
Q3  2019
Meridian Contrarian Fund Add 73.77% 90,000 0.35
Q2  2019
Meridian Contrarian Fund Buy 122,000 0.59

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.